Mannan binding lectin: A two-faced regulator of renal allograft injury?

11Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Complement activation plays an important role in the pathogenesis of renal allograft injury after kidney transplantation. There are three known pathways of complement activation, namely, classical, alternative, and lectin pathways. In renal allograft injury, contradictory results were reported about the role of the lectin pathway activated via mannan binding lectin (MBL). This Commentary discusses the findings by Bay et al. (this issue), who demonstrated a protective role for circulating MBL in the recipient, particularly in non-HLA immunized recipients. © 2012 International Society of Nephrology.

Cite

CITATION STYLE

APA

Damman, J., & Seelen, M. A. (2013). Mannan binding lectin: A two-faced regulator of renal allograft injury? Kidney International. Nature Publishing Group. https://doi.org/10.1038/ki.2012.397

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free